No currently approved drug comes close and there is no FDA-approved drug for MASLD, a condition affecting roughly 1 in 3 adults
Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes
For those participating in clinical trials of retatrutide, or for healthcare professionals seeking to understand the management of GLP-1-related nausea more broadly, several practical strategies are supported by clinical experience with similar licensed medicines
After 40 weeks, people taking retatrutide had average HbA1c reductions of around 1.7 to 1.9 percentage points
You found a compounding pharmacy, got your prescription, started your injections on schedule
Most research teams use sterile bacteriostatic water or sterile water for injection, depending on study length